Hospital Geral de Nova Iguaçu

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• HIV4 trials

Phase

• Phase 1/21 trial
• Phase 41 trial

Status

• Recruiting2 trials
• Active, not recruiting1 trial
• Completed1 trial

Lead sponsor

• Oswaldo Cruz Foundation2 trials
• Fundación Huésped1 trial
• PENTA Foundation1 trial

Running trials

• Recruiting

  ImPrEP LEN Brasil: Twice-Yearly Lenacapavir for HIV Prevention

  NCT07497594· Oswaldo Cruz Foundation· Source

  Contact: José Henrique Pilotto

• Recruiting

  Improving Access to PrEP (HIV Prevention Medication) for People in Underserved Areas of Rio de Janeiro

  NCT07584122· Oswaldo Cruz Foundation· Source

  Contact: José Henrique Pilotto, PhD

• Active, not recruiting

  Safety and Pharmacokinetics Evaluation of Fostemsavir + (OBT) in HIV-1 Infected Children and Adolescents Who Are Failing Their cART and Have Dual- or Triple-class Antiretroviral Resistance

  NCT04648280· Phase 1/2· PENTA Foundation· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• HIV2 recruiting

Closed trials

• Completed

  Dolutegravir-Lamivudine for naïve HIV-Infected Patients With ≤200 CD4/mm3

  NCT04880395· Phase 4· Fundación Huésped· Source